PageOverview.com
 

Websites, domains, hosts that links to uspl.lilly.com

Our database shows, that the website uspl.lilly.com is linked by a total of 17 websites.

 
Number of websites/domains displayed: 17
Results found: 17
 

Websites discovered:

Underarm Testosterone Treatment | AXIRON (testosterone) topical solution
http://pageoverview.com/website-report/axiron.com
AXIRON is a prescription underarm testosterone medication used to help treat men with hypogonadism due to certain medical conditions. Learn about AXIRON and how it can be used as a testosterone treatment.
  • Expected expiration: May 24th in 2017
  • Creation date: May 24th in 2005
  • Renew date: May 19th in 2016
Insulin | BASAGLAR (insulin glargine injection)
http://pageoverview.com/website-report/basaglar.com
BASAGLAR is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
  • Expected expiration: June 2nd in 2018
  • Creation date: June 2nd in 2011
  • Renew date: May 29th in 2017
Osteoporosis Injection Treatment | FORTEO [teriparatide (rDNA origin) injection]
http://pageoverview.com/website-report/forteo.com
FORTEO [teriparatide (rDNA origin) injection] is an osteoporosis treatment medication. If you are an osteoporosis patient at high risk for fracture, learn how FORTEO can help treat your osteoporosis.
    Official Site | Effient® (prasugrel)
    http://pageoverview.com/website-report/effient.com
    Discover Effient®, a treatment option to be taken with aspirin for ACS patients treated with angioplasty. See Prescribing, Safety Info, & Boxed Warning.
    • Expected expiration: July 24th in 2017
    • Creation date: July 24th in 2006
    • Renew date: July 20th in 2016
    Medication to treat ED and BPH symptoms.
    http://pageoverview.com/website-report/cialis.com
    CIALIS for daily use is approved to treat erectile dysfunction (ED) and the frustrating urinary symptoms of benign prostatic hyperplasia (BPH).
    • Expected expiration: August 10th in 2017
    • Creation date: August 10th in 1999
    • Renew date: August 6th in 2016
    Type 2 Diabetes Treatment | Trulicity (dulaglutide) injection
    http://pageoverview.com/website-report/trulicity.com
    Trulicity, an easy to use, once-weekly type 2 diabetes treatment is a GLP-1 receptor agonist for type 2 diabetes. Learn how Trulicity can help lower your blood sugar and A1C.
    • Expected expiration: November 23rd in 2017
    • Creation date: November 23rd in 2010
    • Renew date: November 19th in 2016
    CIALIS (tadalafil) tablets for Healthcare Professionals
    http://pageoverview.com/website-report/cialismd.com
    Learn about CIALIS, the only medication approved to treat patients with erectile dysfunction (ED) and the symptoms of benign prostatic hyperplasia (BPH).
    • Expected expiration: January 11th in 2018
    • Creation date: January 11th in 2002
    • Renew date: January 7th in 2017
    For Healthcare Professionals | CYRAMZA® (ramucirumab)
    http://pageoverview.com/website-report/cyramzahcp.com
    CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).
    • Expected expiration: August 27th in 2017
    • Creation date: August 27th in 2013
    • Renew date: August 23rd in 2016
    Advanced NS NSCLC Treatment | ALIMTA (pemetrexed for injection)
    http://pageoverview.com/website-report/alimta.com
    Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer (NSCLC). Find information about taking ALIMTA for the treatment of advanced NS NSCLC.
    • Expected expiration: August 17th in 2018
    • Creation date: August 17th in 1999
    • Renew date: August 13th in 2017
    Diabetes Treatment - Humalog (insulin lispro injection, USP [rDNA origin])
    http://pageoverview.com/website-report/humalog.com
    Resources and info for adults and children with diabetes. Learn how Humalog rapid-acting mealtime insulin can help with diabetes treatment and management.
    • Expected expiration: May 29th in 2017
    • Creation date: May 30th in 1997
    • Renew date: May 25th in 2016
    For Healthcare Professionals | Effient® tablets
    http://pageoverview.com/website-report/effienthcp.com
    Find information for physicians & healthcare professionals about Effient® (prasugrel) tablets. See full Prescribing & Safety Information including Boxed Warning.
    • Expected expiration: May 21st in 2018
    • Creation date: May 21st in 2008
    • Renew date: May 17th in 2017
    Home
    http://pageoverview.com/website-report/humulin.com
    Humulin R U‐500 is a concentrated insulin used to help control high blood sugar in adults and children taking greater than 200 units of insulin each day.
    • Expected expiration: May 29th in 2017
    • Creation date: May 30th in 1997
    • Renew date: May 25th in 2016
    Plaque Psoriasis Treatment | Taltz (ixekizumab)
    http://pageoverview.com/website-report/taltz.com
    Taltz is a prescription medicine used to treat adults with moderate to severe plaque psoriasis.
    • Expected expiration: November 18th in 2017
    • Creation date: November 18th in 2011
    • Renew date: November 14th in 2016
    Humatrope (somatropin for injection) Patient Site
    http://pageoverview.com/website-report/humatrope.com
    Find information for those dealing with growth hormone deficiency and growth disorders.
    • Expected expiration: May 26th in 2018
    • Creation date: May 27th in 1998
    • Renew date: May 22nd in 2017
    Treatment for certain lung, stomach, and colorectal tumors | CYRAMZA(R) (ramucirumab)
    http://pageoverview.com/website-report/cyramza.com
    CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).
    • Expected expiration: October 5th in 2018
    • Creation date: October 5th in 2011
    • Renew date: October 1st in 2017
    A treatment for certain colorectal and head and neck cancers | ERBITUX (cetuximab)
    http://pageoverview.com/website-report/erbitux.com
    Learn about ERBITUX, a treatment for metastatic colorectal cancer as well as certain types of head and neck cancers.
    • Expected expiration: March 1st in 2018
    • Creation date: March 1st in 2000
    • Renew date: February 25th in 2017
    Soft Tissue Sarcoma (STS) Treatment | Lartruvo (olaratumab)
    http://pageoverview.com/website-report/lartruvo.com
    LARTRUVO (olaratumab) is used with doxorubicin to treat adults with soft tissue sarcoma (STS) that cannot be cured with radiation or surgery.
    • Expected expiration: October 20th in 2018
    • Creation date: October 20th in 2014
    • Renew date: October 16th in 2017
    0.0173 // 2024-05-05 17:58:06
    All Rights reserved 2018 © PageOverview.com